Boston Scientific landed the European CE Mark for its next generation of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) device. The device is used to isolate the left atrial appendage of the heart, the place where stroke-causing blood clots tend to form in patients with non-valvular atrial fibrillation (AFib).
The technology is minimally inv (Read more...)